Skip to main content
AAN.com
Brief Communications
May 14, 2002

Generalized epilepsy with febrile seizures plus: Mutation of the sodium channel subunit SCN1B

May 14, 2002 issue
58 (9) 1426-1429

Abstract

Generalized epilepsy with febrile seizures plus (GEFS+) is an important childhood genetic epilepsy syndrome with heterogeneous phenotypes, including febrile seizures (FS) and generalized epilepsies of variable severity. Forty unrelated GEFS+ and FS patients were screened for mutations in the sodium channel β-subunits SCN1B and SCN2B, and the second GEFS+ family with an SCN1B mutation is described here. The family had 19 affected individuals: 16 with typical GEFS+ phenotypes and three with other epilepsy phenotypes. Site-specific mutation within SCN1B remains a rare cause of GEFS+, and the authors found no evidence to implicate SCN2B in this syndrome.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (wallace.doc)

References

1.
Scheffer IE, Berkovic SF. Generalised epilepsy with febrile seizures plus: a genetic disorder with heterogeneous clinical phenotypes. Brain . 1997; 120: 479–490.
2.
Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalised epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol . 1999; 45: 75–81.
3.
Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalised epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet . 1998; 19: 366–370.
4.
Escayg A, Baulac S, Moulard B, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet . 2000; 24: 343–345.
5.
Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel α1-subunit mutations in generalised epilepsy with febrile seizures plus. Am J Hum Genet . 2001; 68: 859–865.
6.
Escayg A, Heils A, MacDonald B, et al. A novel SCN1A mutation associated with generalised epilepsy with febrile seizures plus—and prevalence of variants in patients with epilepsy. Am J Hum Genet . 2001; 68: 866–873.
7.
Sugawara T, Tsurubuchi Y, Agarwala K, et al. A missense mutation of the Na+ channel αII subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA . 2001; 98: 6384–6389.
8.
Phillips HA, Scheffer IE, Berkovic SF, Hollway GE, Sutherland GR, Mulley JC. Localisation of autosomal dominant nocturnal frontal lobe epilepsy to 20q13.2: the same region as benign neonatal convulsions. Nat Genet . 1995; 10: 117–118.
9.
Huttley GA, Smith MW, Carrington M, O’Brien SJ. A scan for linkage disequilibrium across the human genome. Genetics . 1999; 152: 1711–1722.

Information & Authors

Information

Published In

Neurology®
Volume 58Number 9May 14, 2002
Pages: 1426-1429
PubMed: 12011299

Publication History

Received: December 7, 2000
Accepted: January 4, 2002
Published online: May 14, 2002
Published in issue: May 14, 2002

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

R. H. Wallace, PhD
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
I. E. Scheffer, MBBS PhD
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
G. Parasivam, MSc
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
S. Barnett, BSc(Hons)
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
G. B. Wallace, MBBS
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
G. R. Sutherland, PhD DSc
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
S. F. Berkovic, MD
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.
J. C. Mulley, PhD
From the Centre for Medical Genetics (Drs. Wallace, Sutherland, and Mulley, and S. Barnett), Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide; Department of Medicine (Neurology) (Drs. Scheffer and Berkovic and G. Parasivam), University of Melbourne, Austin and Repatriation Medical Centre, Heidelberg, and Royal Children’s Hospital (Drs. Scheffer and Berkovic), Victoria; Mater Medical Centre (G.B. Wallace), South Brisbane, Queensland; and Department of Genetics (Drs. Wallace and Sutherland), and Department of Paediatrics (Drs. Sutherland and Mulley), University of Adelaide, Australia.

Notes

Address correspondence and reprint requests to Dr. Robyn Wallace, The Bionomics/Women’s and Children’s Hospital Research Facility, 28 Dalgleish Street, Thebarton, South Australia, Australia, 5031; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Identifying individuals with rare disease variants by inferring shared ancestral haplotypes from SNP array data, NAR Genomics and Bioinformatics, 7, 2, (2025).https://doi.org/10.1093/nargab/lqaf033
    Crossref
  2. Heroin Regulates the Voltage-Gated Sodium Channel Auxiliary Subunit, SCN1b, to Modulate Nucleus Accumbens Medium Spiny Neuron Intrinsic Excitability and Cue-Induced Heroin Seeking, eneuro, 12, 3, (ENEURO.0017-25.2025), (2025).https://doi.org/10.1523/ENEURO.0017-25.2025
    Crossref
  3. Development and characterization of the mode-of-action of inhibitory and agonist peptides targeting the voltage-gated sodium channel SCN1B beta-subunit, Journal of Molecular and Cellular Cardiology, 194, (32-45), (2024).https://doi.org/10.1016/j.yjmcc.2024.06.008
    Crossref
  4. Tracing topics and trends in drug‐resistant epilepsy research using a natural language processing–based topic modeling approach , Epilepsia, 65, 4, (861-872), (2024).https://doi.org/10.1111/epi.17890
    Crossref
  5. Beta-subunit-eliminated eHAP expression (BeHAPe) cells reveal subunit regulation of the cardiac voltage-gated sodium channel, Journal of Biological Chemistry, 299, 9, (105132), (2023).https://doi.org/10.1016/j.jbc.2023.105132
    Crossref
  6. Why do febrile seizures involve specifically the developing brain?, Febrile Seizures, (155-178), (2023).https://doi.org/10.1016/B978-0-323-89932-1.00005-6
    Crossref
  7. A founder event causing a dominant childhood epilepsy survives 800 years through weak selective pressure, The American Journal of Human Genetics, 109, 11, (2080-2087), (2022).https://doi.org/10.1016/j.ajhg.2022.10.004
    Crossref
  8. SCN1B Genetic Variants: A Review of the Spectrum of Clinical Phenotypes and a Report of Early Myoclonic Encephalopathy, Children, 9, 10, (1507), (2022).https://doi.org/10.3390/children9101507
    Crossref
  9. The burden of epilepsy and unmet need in people with focal seizures, Brain and Behavior, 12, 9, (2022).https://doi.org/10.1002/brb3.2589
    Crossref
  10. Genetics in Epilepsy, Neurologic Clinics, 39, 3, (743-777), (2021).https://doi.org/10.1016/j.ncl.2021.05.005
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share